Zag Bio is a clinical-stage biotechnology company developing thymus-targeted therapies for autoimmune diseases. The company engineers bifunctional antibodies that deliver self-antigens to antigen-presenting cells in the thymus, harnessing the body's natural process of central immune tolerance so developing immune cells learn to recognize… - View it on GitHub